Table 1.

Clinical data for study participants

	Age	Gender	Handed	Depression	Current mA	PW µs	Psychiatric Comorbidity	Initial HmD	Chronic 1 Year HmD	Medications
1	35	F	R	unipolar	0.75	500	h/o bulimia, etoh: FR	29	14	disulfiram, fish oil, fluoxetine, modafinil
2	55	M	R	unipolar	1.50	250	h/o etoh, polysubstanc e abuse: FR	29	32	acetylsalicylic acid, bupropion, diphenhydramine, fish oil, pravastatin, sertraline, terazosin, triamcinolone acetonide,
3	46	F	R	unipolar	1.50	500	None	18	16	acetylsalicylic acid, bupropion, caffeine, venlafaxine;
4	47	F	R	unipolar	1.50	500	Panic disorder	32	13	calcium, conjugated estrogens, fexofenadine, trazodone, clonazepam, fluoxetine, modafinil, omeprazole, quetiapine
5	32	M	L	bipolar	1.00	500	h/o etoh, cocaine dep (FR); dysthymia; sexual paraphilia	27	20	clonazepam, fluoxetine, modafinil,omeprazole, quetiapine
6	52	F	R	unipolar	0.75	250	None	24	25	calcium, dyazide, fluvoxamine, mirtazapine, naproxen, oxybutynin, conjugated estrogens, medroxyprogesterone acetate, glucosamine
7	27	M	R	unipolar	0.75	500	OCD, panic disorder	23	26	Sertraline
8	54	F	R	unipolar	0.50	250	h/o etoh & PTSD	37	27	acetylsalicylic Acid

^*Pt, patient number; Hand, handedness; M, male; F, female; R, right-handed; L, left-handed; mA, milliamp; PW, pulse width; µs, microsecond; etoh, alcohol dependence; FR, full remission; OCD, obsessive compulsive disorder; PTSD, post-traumatic stress disorder; new medication (lamotrigine) added for patient 6, 6 months following implant & discontinued at 9 months.